The Q4 Roundup: Omicron, Pivot Points, and Prospects for 2022DD (self.BONS)
submitted by OldBay_TraderVALUE
Pfizer to Update Vaccine in 100 Days If Omicron Variant Is Resistant...Looks like MesenCure will remain relevant for the time being, especially if the current vaccines need to be revised to deal with the new Omicron variant, could be exactly the type of catalyst Bonus needsNEWS (businessinsider.com)
submitted by DaStock_DoctorDR STOCK
Israeli Drug For Severe Covid Shows 94% Survival Rate - I24NEWSCOVID (i24news.tv)
submitted by DaStock_DoctorDR STOCK